Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Rapid Response platform for combating COVID-19 variants
The adenovirus vector platform we have built is optimized for fast and massive production of vaccines.
Therefore, it is possible to respond quickly to different COVID-19 variants.